Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Denosumab on the Pharmacokinetics of Etanercept in Postmenopausal Women With Low Bone Mineral Density and Rheumatoid Arthritis

NCT01294397 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01294397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01294397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Denosumab on the Pharmacokinetics of Etanercept in Postmenopausal Women With Low Bone Mineral Density and Rheumatoid Arthritis
Lead sponsor
Amgen
Phase
Phase 1
Overall status
Terminated
Start date
March 31, 2011
Completion date
January 31, 2016
Enrollment
19 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

osteopenia, osteoporosis, postmenopausal, rheumatoid arthritis